Formulation Development Outsourcing Market By Services Type, By Route of Formulation, By End-user : Global Opportunity Analysis and Industry Forecast, 2021-2031

Description

List of Tables

The global formulation development outsourcing market is envisioned to garner $6518.8 million by 2031, growing from $3156.8 million in 2021 at a CAGR of 9.0% from 2022 to 2031. The process of assessing the patentability, lifetime, and success of pharmaceutical products is referred to as formulation development. Pre-formulation activities include the development and characterization of analytical assays, excipient screening to stabilize or improve the product's solubility, and dosage form. Due to time constraints and a lack of internal resources, it is frequently outsourced. Outsourcing formulation development has a lot of advantages as well, including shortened timescales, easier access to knowledge, and increased protection against defective products.

Drug developers at all levels are becoming interested in outsourcing pharmaceutical formulation development and manufacture, particularly in developing nations like India. The rising need for novel medications as a result of the significant burden of infectious and chronic diseases is one of the main factors driving the demand for formulation development. In addition, there is a strong emphasis on creating poorly water-soluble chemicals to increase bioavailability and patent expirations. The necessity for clinical trials to identify a cure for contagious viruses has also been influenced by the COVID-19 outbreak. As a result, substantial funds have been spent on R&D to create medicines, which are predicted to boost the industry.

It is anticipated that higher R&D expenses will raise demand for outsourcing formulation development. Small and medium-sized pharmaceutical enterprises that lack the requisite resources frequently use outsourcing services for formulation development. Due to trial-related expenses, the majority of pharmaceutical businesses use it to shorten the time spent on outsourcing services for formulation development. The pharmaceutical industry's growing reliance on collaborations with academic institutions is caused by the growth of the formulation development outsourcing industry.

The formulation development outsourcing market is expected to be restrained owing to high amount of budget required for outsourcing drug development by the companies. Additionally, the complexity of the substances is growing for formulators. Increases in the price and demand for various medicines and raw materials have the potential to have a substantial negative impact on the market value of formulation development outsourcing. Incorporating various active chemicals, tightening restrictions, shifting societal and customer preferences, and environmental considerations all have an impact on the creation of a product, as do usage and eventual decomposition. In addition to their total environmental impact, formulators are concerned with how their products will benefit consumers and patients.

The number of pharmaceutical and biopharmaceutical businesses outsourcing their work has led to an expansion of the formulation development outsourcing market. The COVID-19 pandemic is expected to have a positive impact on the formulation drug outsourcing market. The high demand for effective drug or vaccine discovery among healthcare professionals, researchers and scientists to treat the viral infection has boosted the research and development activities. Many contract formulation development outsourcing companies became active and started taking drug development formulation projects from major companies and even research institutes.

The key players profiled in this report include: Charles River Laboratories, Syngene International Limited, Catalent, Inc, Piramal Pharma Ltd., Intertek Group plc, Thermo Fisher Scientific, Eurofins Scientific, Laboratory Corporation of America Holdings., Dr. Reddy's Laboratories Ltd., and EMERGENT.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the formulation development outsourcing market analysis from 2021 to 2031 to identify the prevailing formulation development outsourcing market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the formulation development outsourcing market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global formulation development outsourcing market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Services Type

Pre-Formulation
Formulation Development

By Route of Formulation

Oral
Injectable
Others

By End-user

Pharmaceutical Industries
Research and Academic Institutes

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- United Arab Emirates
- South Africa
- Rest of LAMEA

Key Market Players

Charles River Laboratories International, Inc.
syngene international limited
Catalent Inc
Piramal Pharma Limited
Intertek Group Plc
Thermo Fisher Scientific Inc.
Eurofins Scientific
Laboratory Corporation of America Holdings
Dr Reddy's Laboratories Ltd.
Emergent BioSolutions, Inc.

Product Code: A31380

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
3.6. Key Regulation Analysis
3.7. Market Share Analysis
3.8. Patent Landscape
3.9. Regulatory Guidelines
3.10. Value Chain Analysis

CHAPTER 4: FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Pre-Formulation
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Formulation Development
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country

CHAPTER 5: FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Oral
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Injectable
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Others
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country

CHAPTER 6: FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Pharmaceutical Industries
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. Research and Academic Institutes
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country

CHAPTER 7: FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY REGION

7.1. Overview
- 7.1.1. Market size and forecast By Region
7.2. North America
- 7.2.1. Key trends and opportunities
- 7.2.2. Market size and forecast, by Services Type
- 7.2.3. Market size and forecast, by Route of Formulation
- 7.2.4. Market size and forecast, by End-user
- 7.2.5. Market size and forecast, by country
  - 7.2.5.1. U.S.
  - 7.2.5.1.1. Key market trends, growth factors and opportunities
  - 7.2.5.1.2. Market size and forecast, by Services Type
  - 7.2.5.1.3. Market size and forecast, by Route of Formulation
  - 7.2.5.1.4. Market size and forecast, by End-user
  - 7.2.5.2. Canada
  - 7.2.5.2.1. Key market trends, growth factors and opportunities
  - 7.2.5.2.2. Market size and forecast, by Services Type
  - 7.2.5.2.3. Market size and forecast, by Route of Formulation
  - 7.2.5.2.4. Market size and forecast, by End-user
  - 7.2.5.3. Mexico
  - 7.2.5.3.1. Key market trends, growth factors and opportunities
  - 7.2.5.3.2. Market size and forecast, by Services Type
  - 7.2.5.3.3. Market size and forecast, by Route of Formulation
  - 7.2.5.3.4. Market size and forecast, by End-user
7.3. Europe
- 7.3.1. Key trends and opportunities
- 7.3.2. Market size and forecast, by Services Type
- 7.3.3. Market size and forecast, by Route of Formulation
- 7.3.4. Market size and forecast, by End-user
- 7.3.5. Market size and forecast, by country
  - 7.3.5.1. Germany
  - 7.3.5.1.1. Key market trends, growth factors and opportunities
  - 7.3.5.1.2. Market size and forecast, by Services Type
  - 7.3.5.1.3. Market size and forecast, by Route of Formulation
  - 7.3.5.1.4. Market size and forecast, by End-user
  - 7.3.5.2. UK
  - 7.3.5.2.1. Key market trends, growth factors and opportunities
  - 7.3.5.2.2. Market size and forecast, by Services Type
  - 7.3.5.2.3. Market size and forecast, by Route of Formulation
  - 7.3.5.2.4. Market size and forecast, by End-user
  - 7.3.5.3. France
  - 7.3.5.3.1. Key market trends, growth factors and opportunities
  - 7.3.5.3.2. Market size and forecast, by Services Type
  - 7.3.5.3.3. Market size and forecast, by Route of Formulation
  - 7.3.5.3.4. Market size and forecast, by End-user
  - 7.3.5.4. Spain
  - 7.3.5.4.1. Key market trends, growth factors and opportunities
  - 7.3.5.4.2. Market size and forecast, by Services Type
  - 7.3.5.4.3. Market size and forecast, by Route of Formulation
  - 7.3.5.4.4. Market size and forecast, by End-user
  - 7.3.5.5. Italy
  - 7.3.5.5.1. Key market trends, growth factors and opportunities
  - 7.3.5.5.2. Market size and forecast, by Services Type
  - 7.3.5.5.3. Market size and forecast, by Route of Formulation
  - 7.3.5.5.4. Market size and forecast, by End-user
  - 7.3.5.6. Rest of Europe
  - 7.3.5.6.1. Key market trends, growth factors and opportunities
  - 7.3.5.6.2. Market size and forecast, by Services Type
  - 7.3.5.6.3. Market size and forecast, by Route of Formulation
  - 7.3.5.6.4. Market size and forecast, by End-user
7.4. Asia-Pacific
- 7.4.1. Key trends and opportunities
- 7.4.2. Market size and forecast, by Services Type
- 7.4.3. Market size and forecast, by Route of Formulation
- 7.4.4. Market size and forecast, by End-user
- 7.4.5. Market size and forecast, by country
  - 7.4.5.1. China
  - 7.4.5.1.1. Key market trends, growth factors and opportunities
  - 7.4.5.1.2. Market size and forecast, by Services Type
  - 7.4.5.1.3. Market size and forecast, by Route of Formulation
  - 7.4.5.1.4. Market size and forecast, by End-user
  - 7.4.5.2. Japan
  - 7.4.5.2.1. Key market trends, growth factors and opportunities
  - 7.4.5.2.2. Market size and forecast, by Services Type
  - 7.4.5.2.3. Market size and forecast, by Route of Formulation
  - 7.4.5.2.4. Market size and forecast, by End-user
  - 7.4.5.3. India
  - 7.4.5.3.1. Key market trends, growth factors and opportunities
  - 7.4.5.3.2. Market size and forecast, by Services Type
  - 7.4.5.3.3. Market size and forecast, by Route of Formulation
  - 7.4.5.3.4. Market size and forecast, by End-user
  - 7.4.5.4. South Korea
  - 7.4.5.4.1. Key market trends, growth factors and opportunities
  - 7.4.5.4.2. Market size and forecast, by Services Type
  - 7.4.5.4.3. Market size and forecast, by Route of Formulation
  - 7.4.5.4.4. Market size and forecast, by End-user
  - 7.4.5.5. Australia
  - 7.4.5.5.1. Key market trends, growth factors and opportunities
  - 7.4.5.5.2. Market size and forecast, by Services Type
  - 7.4.5.5.3. Market size and forecast, by Route of Formulation
  - 7.4.5.5.4. Market size and forecast, by End-user
  - 7.4.5.6. Rest of Asia-Pacific
  - 7.4.5.6.1. Key market trends, growth factors and opportunities
  - 7.4.5.6.2. Market size and forecast, by Services Type
  - 7.4.5.6.3. Market size and forecast, by Route of Formulation
  - 7.4.5.6.4. Market size and forecast, by End-user
7.5. LAMEA
- 7.5.1. Key trends and opportunities
- 7.5.2. Market size and forecast, by Services Type
- 7.5.3. Market size and forecast, by Route of Formulation
- 7.5.4. Market size and forecast, by End-user
- 7.5.5. Market size and forecast, by country
  - 7.5.5.1. Brazil
  - 7.5.5.1.1. Key market trends, growth factors and opportunities
  - 7.5.5.1.2. Market size and forecast, by Services Type
  - 7.5.5.1.3. Market size and forecast, by Route of Formulation
  - 7.5.5.1.4. Market size and forecast, by End-user
  - 7.5.5.2. Saudi Arabia
  - 7.5.5.2.1. Key market trends, growth factors and opportunities
  - 7.5.5.2.2. Market size and forecast, by Services Type
  - 7.5.5.2.3. Market size and forecast, by Route of Formulation
  - 7.5.5.2.4. Market size and forecast, by End-user
  - 7.5.5.3. United Arab Emirates
  - 7.5.5.3.1. Key market trends, growth factors and opportunities
  - 7.5.5.3.2. Market size and forecast, by Services Type
  - 7.5.5.3.3. Market size and forecast, by Route of Formulation
  - 7.5.5.3.4. Market size and forecast, by End-user
  - 7.5.5.4. South Africa
  - 7.5.5.4.1. Key market trends, growth factors and opportunities
  - 7.5.5.4.2. Market size and forecast, by Services Type
  - 7.5.5.4.3. Market size and forecast, by Route of Formulation
  - 7.5.5.4.4. Market size and forecast, by End-user
  - 7.5.5.5. Rest of LAMEA
  - 7.5.5.5.1. Key market trends, growth factors and opportunities
  - 7.5.5.5.2. Market size and forecast, by Services Type
  - 7.5.5.5.3. Market size and forecast, by Route of Formulation
  - 7.5.5.5.4. Market size and forecast, by End-user

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

9.1. Charles River Laboratories International, Inc.
- 9.1.1. Company overview
- 9.1.2. Key Executives
- 9.1.3. Company snapshot
9.2. syngene international limited
- 9.2.1. Company overview
- 9.2.2. Key Executives
- 9.2.3. Company snapshot
9.3. Catalent Inc
- 9.3.1. Company overview
- 9.3.2. Key Executives
- 9.3.3. Company snapshot
9.4. Piramal Pharma Limited
- 9.4.1. Company overview
- 9.4.2. Key Executives
- 9.4.3. Company snapshot
9.5. Intertek Group Plc
- 9.5.1. Company overview
- 9.5.2. Key Executives
- 9.5.3. Company snapshot
9.6. Thermo Fisher Scientific Inc.
- 9.6.1. Company overview
- 9.6.2. Key Executives
- 9.6.3. Company snapshot
9.7. Eurofins Scientific
- 9.7.1. Company overview
- 9.7.2. Key Executives
- 9.7.3. Company snapshot
9.8. Laboratory Corporation of America Holdings
- 9.8.1. Company overview
- 9.8.2. Key Executives
- 9.8.3. Company snapshot
9.9. Dr Reddy's Laboratories Ltd.
- 9.9.1. Company overview
- 9.9.2. Key Executives
- 9.9.3. Company snapshot
9.10. Emergent BioSolutions, Inc.
- 9.10.1. Company overview
- 9.10.2. Key Executives
- 9.10.3. Company snapshot